Case Detail
Case Title | VANDA PHARMACEUTICALS INC. v. FOOD AND DRUG ADMINISTRATION | |||||||||||||||||||||||||||||||||||||||
District | District of Columbia | |||||||||||||||||||||||||||||||||||||||
City | Washington, DC | |||||||||||||||||||||||||||||||||||||||
Case Number | 1:2023cv02327 | |||||||||||||||||||||||||||||||||||||||
Date Filed | 2023-08-11 | |||||||||||||||||||||||||||||||||||||||
Date Closed | Open | |||||||||||||||||||||||||||||||||||||||
Judge | Judge Ana C. Reyes | |||||||||||||||||||||||||||||||||||||||
Plaintiff | VANDA PHARMACEUTICALS INC. | |||||||||||||||||||||||||||||||||||||||
Case Description | Vanda Pharmaceuticals submitted three FOIA requests to the FDA for records. Vanda's first FOIA request asked for records concerning any bioequivalence study or dissolution study submitted during FDA's consideration of Teva's ANDA. The agency acknowledged receipt of the request. Vanda's second FOIA request asked for records concerning bioequivalence studies for Apotex's ANDA. The agency acknowledged receipt of the request. Vanda submitted a third request for records concerning bioequivalence studies concerning MSN's ANDA. The agency acknowledged receipt of the request. After hearing nothing further from the agency concerning any of its three requests, Vanda Pharmaceuticals filed suit. Complaint issues: Failure to respond within statutory time limit, Litigation - Attorney's fees, Adequacy - Search | |||||||||||||||||||||||||||||||||||||||
Defendant | FOOD AND DRUG ADMINISTRATION | |||||||||||||||||||||||||||||||||||||||
Documents | Docket Complaint Complaint attachment 1 Complaint attachment 2 Complaint attachment 3 Complaint attachment 4 Complaint attachment 5 Complaint attachment 6 Complaint attachment 7 Complaint attachment 8 Complaint attachment 9 Complaint attachment 10 | |||||||||||||||||||||||||||||||||||||||
User-contributed Documents | ||||||||||||||||||||||||||||||||||||||||
![]() | ||||||||||||||||||||||||||||||||||||||||
|